How can follicle-stimulating hormone (FSH) eluting nanosuspensions be designed for controlled release to enhance multiple ovulation in elite indigenous cattle?
FSH-eluting nanosuspensions for cattle can be designed by:
Formulation design: Encapsulating FSH within biodegradable polymers (e.g., PLGA, chitosan, alginate) to protect hormone activity and allow gradual release.
Particle engineering: Controlling particle size, surface charge, and crystallinity to fine-tune release rates and improve bioavailability.
Stabilization: Using cryoprotectants, surfactants, or PEGylation to preserve FSH activity during storage and administration.
Release modulation: Adjusting polymer composition, crosslinking density, and FSH loading to achieve sustained plasma concentrations over several days.
Delivery route: Designing the nanosuspension for intramuscular or subcutaneous injection to reduce repeated dosing and animal stress.
Together, these strategies enable steady FSH levels, promoting controlled superovulation in elite indigenous cattle while minimizing hormone wastage and variability.
FSH-eluting nanosuspensions for controlled-release multiple-ovulation protocols can be rationally designed by encapsulating FSH in biodegradable carriers (PLGA, chitosan, hyaluronic acid or similar), engineering particle size and surface charge to tune release, adding stabilizers to preserve bioactivity, validating release kinetics in vitro and pharmacokinetics in vivo, and then testing graded doses in small controlled trials to identify protocols that maximize multiple-ovulation while minimizing adverse effects and handling complexity.